Section 856IAC6-1-3. Prescription monitoring program

   (a) Each time a Schedule II, III, IV, or V controlled substance is dispensed, the dispenser shall transmit to the central repository information outlined in IC 35-48-7-8 [IC 35-48-7-8 was repealed by P.L.3-2008, SECTION 269, effective March 13, 2008.].

  (b) Dispensers reporting more than twenty (20) Schedule II, III, IV, or V prescriptions in any given month must transmit to the central repository information outlined in IC 35-48-7-8 [IC 35-48-7-8 was repealed by P.L.3-2008, SECTION 269, effective March 13, 2008.] utilizing one (1) of the following:

(1) An electronic device compatible with the receiving device of the central repository.

(2) A computer diskette.

(3) A magnetic tape.

  (c) Dispensers reporting less than twenty (20) Schedule II, III, IV, or V prescriptions in any given month may submit data utilizing a universal claim form or transmit the information utilizing the ways outlined in subsection (b).

  (d) The committee may grant a waiver to a dispenser which is unable to transmit the required data in accordance with subsection (b) for a period of one hundred eighty (180) days from the effective date of this rule which one hundred eighty (180) day period may be extended by the committee at its discretion. During the effective period of the waiver and any extension granted by the committee, the dispenser shall submit the required data in a format acceptable to the committee. (Indiana Board of Pharmacy; 856 IAC 6-1-3; filed Oct 6, 1994, 1:30 p.m.: 18 IR 267; readopted filed Nov 30, 2001, 2:47 p.m.: 25 IR 1344; filed Apr 16, 2004, 10:07 a.m.: 27 IR 2731; readopted filed Nov 17, 2010, 9:36 a.m.: 20101215-IR-856100487RFA) NOTE: Transferred from the Controlled Substances Advisory Committee (858 IAC 2-1-3) to the Indiana Board of Pharmacy (856 IAC 6-1-3) by P.L.84-2010, SECTION 70, effective July 1, 2010.